Figure 4From: Dose-response relationship in cisplatin-treated breast cancer xenografts monitored with dynamic contrast-enhanced ultrasoundMVD changes after treatment with different dose cisplatin. (A) On days 3 and 7, MVD significantly decreased in group C when compared with group A and B, and further decreased in group B as compared with group A on day 7 (* = P < 0.05). (B) Photomicrographs of CD34 stained sections of the three groups on days 0, 3, and 7. Scale bars: 100 μmBack to article page